Infinitus B-Circulation Aids
Natural health product licensed in Canada
- Other names
- B-Circulation Aids
- Licence holder
- Infinitus Innovations (Canada) Inc.
- NPN or DIN-HM
- 80080064
- Status
- Active licence
- Licence date
- 18 September 2017
- Revision date
- 31 August 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Perilla frutescens (L.) Britton: Seule l'utilisation du chemotype aldéhyde est autorisée
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Panax notoginseng Source : Racine | 30.1 milligramme | Not calculated |
| Panax notoginseng Source : Rhizome | 30.1 milligramme | Not calculated |
| Perilla frutescens Source : Fruit Extract : Matériel brut sec Extraction ratio : 2:1 Dry plant equivalent : 350 milligramme | 175 milligramme | Not calculated |
| Salvia miltiorrhiza Source : Racine et rhizome Extract : Matériel brut sec Extraction ratio : 4.437:1 Dry plant equivalent : 157.5 milligramme | 35.5 milligramme | Not calculated |
| Crataegus pinnatifida Source : Fruit Extract : Matériel brut sec Extraction ratio : 4.437:1 Dry plant equivalent : 157.5 milligramme | 35.5 milligramme | Not calculated |
| Alisma plantago-aquatica subsp. orientale Source : Rhizome Extract : Matériel brut sec Extraction ratio : 4.437:1 Dry plant equivalent : 105.15 milligramme | 23.7 milligramme | Not calculated |
| Ginkgo biloba Source : Feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 1,200 milligramme Potency : 6 % Terpene lactones | 24 milligramme | Not calculated |
| Ginkgo biloba Source : Feuille Potency : 24 % Flavonoid glycosides | Not specified | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Cellulose microcristalline, Inuline, Maltodextrine, Amidon de maïs
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Combination of Traditional Chinese Medicine Ingredients. Helps to support peripheral circulation and to enhance cognitive function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. If you are taking prescription medications, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are taking medications for diabetes, high blood pressure, or seizures.
- Contre-indications
If you are pregnant or breastfeeding, do not use this product. Do not use if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding.
Source
Official Health Canada record, licence 80080064
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging